Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Columbia seeks FDA approval of Crinone

Aug. 9, 1996

Aldose reductase inhibitors disclosed by Nippon Zoki

Aug. 9, 1996

FDA approves phaseI/II trial of VivoRx's BetaRx-P

Aug. 9, 1996

FDA approves expanded date labelling for LeukoNet

Aug. 9, 1996

Amgen and Kirin sign NESP collaboration

Aug. 9, 1996

Yamanouchi reports squalene synthase inhibitors

Aug. 9, 1996

Alfa Wasserman reveals antioxidant hypolipidemic compounds

Aug. 9, 1996

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

Duphar reports Vitamin D compounds with multiple therapeutic activity

Aug. 9, 1996

Comparative study results of Systen and Menorest

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...